Clinical Trial Update: A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating a molecular probe that targets BCMA for the clinical diagnosis of multiple myeloma. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Peking University First Hospital | Conditions: Multiple Myeloma and Malignant Plasma Cell Neoplasms | EARLY_Phase 1 | Status: RECRUITING